People | September 30, 2025
GSK names Luke Miels as next CEO
Miels will formally assume the role on January 1, 2026
Miels will formally assume the role on January 1, 2026
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Ultra-high purity surfactant for biologics and parenteral drug formulations
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins
Merck opens first climate-neutral manufacturing facility in Ireland
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
Subscribe To Our Newsletter & Stay Updated
